The Search for New Drugs: Part I

The transcript discusses Novartis' R&D strategies, highlighting the challenges and advantages of being a large pharmaceutical company. It covers the importance of innovation, investment in gene and cell therapies, and the role of digital technology and AI in reducing costs. The conversation also touches on the pricing of gene therapies and the need for healthcare system adaptations. Additionally, it explores the potential return to antibiotics and the role of telemedicine in reaching new demand pockets.

What new insight or understanding did you gain from this video?